These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12660076)

  • 21. [Losartan, new angiotensin receptor antagonist--a challenge for enzyme converting angiotensin inhibitors?].
    Chabielska E; Pawlak R
    Wiad Lek; 1995; 48(1-12):242-5. PubMed ID: 9638249
    [No Abstract]   [Full Text] [Related]  

  • 22. Losartan ameliorates progression of glomerular structural changes in diabetic KKAy mice.
    Sasaki M; Uehara S; Ohta H; Taguchi K; Kemi M; Nishikibe M; Matsumoto H
    Life Sci; 2004 Jul; 75(7):869-80. PubMed ID: 15183078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of the evenness of the antihypertensive effect of losartan and captopril by using a 24-hour monitoring of arterial pressure].
    Gorbunov VM; Savina LV; Metelitsa VI; Deev AD
    Ter Arkh; 2001; 73(2):38-43. PubMed ID: 11338852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
    Abe M; Okada K; Maruyama T; Matsumoto K
    Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan.
    Avanza AC; El Aouar LM; Mill JG
    Arq Bras Cardiol; 2000 Feb; 74(2):103-17. PubMed ID: 10904284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative study of losartan and enalapril on erythropoiesis and renal function in hypertensive patients with renal parenchymal disease.
    Shand BI; Lynn KL
    Clin Nephrol; 2000 Nov; 54(5):427-8. PubMed ID: 11105808
    [No Abstract]   [Full Text] [Related]  

  • 28. [Fewer cases of stroke, atrial fibrillation, diabetes and renal insufficiency. Good treatment of hypertension is more than lowering of blood pressure].
    Baumgart P
    MMW Fortschr Med; 2008 Jan; 150(1-2):52-3. PubMed ID: 18300647
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Angiotensin-II-antagonism: new hope for the management of cardiac insufficiency].
    Z Kardiol; 1997 Sep; 86(9 Suppl Angio):1-4. PubMed ID: 9373391
    [No Abstract]   [Full Text] [Related]  

  • 31. [Symposium on future prospects of angiotensin converting enzyme. Presentation of perindopril, a new and potent ACE inhibitor. Perindopril exerts an efficacious and rapid inhibition of ACE in plasma as well as in tissues].
    Med Clin (Barc); 1991 Apr; 96(16):suppl 2 p.. PubMed ID: 2051826
    [No Abstract]   [Full Text] [Related]  

  • 32. Angiotensin-converting-enzyme inhibitors and diuretics for hypertension.
    Krut LH
    N Engl J Med; 2003 Jul; 349(1):90-3; author reply 90-3. PubMed ID: 12846227
    [No Abstract]   [Full Text] [Related]  

  • 33. [Organ protection by angiotensin II receptor blockers].
    Kumagai H; Onami T; Takimoto C; Iigaya K; Saruta T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():569-73. PubMed ID: 15171437
    [No Abstract]   [Full Text] [Related]  

  • 34. Angiotensin-converting-enzyme inhibitors and diuretics for hypertension.
    Pickering TG
    N Engl J Med; 2003 Jul; 349(1):90-3; author reply 90-3. PubMed ID: 12840099
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapeutic strategy for patients with stable-stage chronic kidney failure].
    Takamitsu Y
    Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):477-82. PubMed ID: 15052806
    [No Abstract]   [Full Text] [Related]  

  • 36. ACE inhibitors still the drug of choice for heart failure--and more.
    Topol E
    Lancet; 1999 Nov; 354(9192):1797. PubMed ID: 10577651
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria.
    Ellis D; Vats A; Moritz ML; Reitz S; Grosso MJ; Janosky JE
    J Pediatr; 2003 Jul; 143(1):89-97. PubMed ID: 12915830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Who is fooling us?
    Mourad JJ; Safar ME; O'Rourke MF
    Lancet; 2002 Jul; 360(9326):89. PubMed ID: 12114069
    [No Abstract]   [Full Text] [Related]  

  • 39. Ventricular hypertrophy and hypertension: prognostic elements and implications for management.
    Krauser DG; Devereux RB
    Herz; 2006 Jun; 31(4):305-16. PubMed ID: 16810470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of hypertension.
    Fogo A; Kon V
    Semin Nephrol; 1996 Nov; 16(6):555-66. PubMed ID: 9125800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.